fashion -WSS

fashion

author：explore 2025-09-30 15:23:09 - browse：95

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Lindsay Lohan welcomes 1st child with husband Bader Shammas

hotspot

WSS

New warning issued for rebooking air travel after delays, cancellations

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Why the Crimean Bridge is key to Russia's war in Ukraine

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

knowledge

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

A preacher's new calling: Diversifying neuroscience research

Medical leaders decry Supreme Court decision on affirmative action

Ebola public health emergency is over, WHO declares

Drug repurposing or repositioning? The language matters

At JPM 2024, hospital systems pitch financial strength to investors

Sports medicine is finally prioritizing gender equality

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Hollywood unions extend contract negotiations for actors

Gene therapy denied for Afghan refugee whose father aided U.S.

hotspot

Man who had jail sentence commuted by Trump arrested again

Ebola public health emergency is over, WHO declares

At JPM 2024, hospital systems pitch financial strength to investors

Seattle police shoot person suspected in downtown stabbing

Trump got a 'target letter.' What is one and what does it mean?

Ascension's ugly legal battle over care for poor patients in Texas

knowledge

hotspot

focus

knowledge